Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Prurigo Nodularis Treatment Market Size By Product, By Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027

Published by Global Market Insights Inc. Product code 998829
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Prurigo Nodularis Treatment Market Size By Product, By Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027
Published: April 5, 2021 Content info: 110 Pages
Description

Title:
Prurigo Nodularis Treatment Market Size By Product (Antihistamines, Capsaicin Cream, Corticosteroids, Emollients), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027.

The prurigo nodularis treatment market is projected to witness significant growth over the coming years attributing to major factors such as rising demand for better medication, increasing adoption of antihistamines, growing investment in R&D, and burgeoning demand for advanced products.

Prurigo nodularis or PN is a skin condition where hard crusty lumps form on the human skin, which itch intensely. The bumps on the skin could range in size from extremely small to around half inch in diameter. Here the total number of modules could usually vary from 2 to 200.

The treatment of Prurigo nodularis could be quite challenging since people diagnosed with the disease might respond to treatments in a different manner. Due to high intensity of the itch, patients with PN might tend to try numerous different treatments to obtain the most relief. In fact, for numerous people, usually a combination of multiple treatments might be needed find out what would work best for them.

The prurigo nodularis treatment market is segmented in terms of product type, distribution channel, and regional landscape.

In terms of product type, the overall market is classified into emollients, corticosteroids, capsaicin cream, antihistamines, and others. Among these, antihistamines segment is likely to increase at a CAGR of 5.1% over the forecast time period. The segment will witness high adoption owing to the escalating use of antihistamines during first-line therapy for the management of allergic reactions.

These products come in the form of chewable tablets, liquids, pills, capsules, as well as eye drops. Antihistamines also come in injectable forms used largely in health care settings. In addition, antihistamines is known to treat allergy symptoms such as runny and itchy eyes, nasal passages swelling, runny nose, congestion and sneezing, hives as well as other skin rashes.

With respect to distribution channel, the market for prurigo nodularis treatment is categorized into retail pharmacies, online pharmacies, and hospital pharmacies. In 2020, the hospital pharmacies segment held a market share of about 27.5%. Going forward, the segment will witness robust growth owing to increasing demand for better medication for patients. Additionally, high patient volume in hospitals will also boost the segmental growth.

From a regional frame of reference, the prurigo nodularis treatment market in North America is expected to witness substantial growth. Numerous key factors such as the growing investment in R&D, demand for advanced products, and launch of novel therapy by local players in the U.S. is fueling the business outlook. The U.S. market held a valuation of more than $200 million in 2020 and is estimated to progress at rapid pace over the projected time period.

Table of Contents
Product Code: 3849

Table of Contents

Chapter 1. Methodology

  • 1.1. Market definitions
  • 1.2. Base estimates and working
    • 1.2.1. North America
    • 1.2.2. Europe
    • 1.2.3. Asia Pacific
    • 1.2.4. LATAM
    • 1.2.5. MEA
  • 1.3. Forecast calculations
  • 1.4. Data validation
  • 1.5. Data sources
    • 1.5.1. Secondary
      • 1.5.1.1. Paid sources
      • 1.5.1.2. Unpaid sources
    • 1.5.2. Primary

Chapter 2. Executive Summary

  • 2.1. Prurigo nodularis treatment industry 360 degree synopsis, 2016 - 2027 (USD Million)
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Distribution channel trends
    • 2.1.4. Regional trends

Chapter 3. Prurigo Nodularis Treatment Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2016- 2027 (USD Million)
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Growing pharmaceutical and biotechnology industry
      • 3.3.1.2. Growing focus on orphan drug development
      • 3.3.1.3. Increasing prevalence of prurigo nodularis treatment market in developing nations
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. No approved targeted therapy/drug in the market
  • 3.4. Growth potential analysis
    • 3.4.1. By product
    • 3.4.2. By distribution channel
  • 3.5. COVID-19 impact analysis
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2020
    • 3.7.1. Company matrix analysis, 2020
  • 3.8. PESTEL analysis

Chapter 4. Prurigo Nodularis Treatment Market, By Product

  • 4.1. Key segment trends
  • 4.2. Antihistamines
    • 4.2.1. Market size, by region, 2016 - 2027 (USD Million)
  • 4.3. Capsaicin Cream
    • 4.3.1. Market size, by region, 2016 - 2027 (USD Million)
  • 4.4. Corticosteroids
    • 4.4.1. Market size, by region, 2016 - 2027 (USD Million)
  • 4.5. Emollients
    • 4.5.1. Market size, by region, 2016 - 2027 (USD Million)
  • 4.6. Others
    • 4.6.1. Market size, by region, 2016 - 2027 (USD Million)

Chapter 5. Prurigo Nodularis Treatment Market, By Distribution Channel

  • 5.1. Key segment trends
  • 5.2. Hospital Pharmacies
    • 5.2.1. Market size, by region, 2016 - 2027 (USD Million)
  • 5.3. Retail Pharmacies
    • 5.3.1. Market size, by region, 2016 - 2027 (USD Million)
  • 5.4. Online Pharmacies
    • 5.4.1. Market size, by region, 2016 - 2027 (USD Million)

Chapter 6. Prurigo Nodularis Treatment Market, By Region

  • 6.1. Key regional trends
  • 6.2. North America
    • 6.2.1. Market size, by country, 2016 - 2027 (USD Million)
    • 6.2.2. Market size, by product, 2016 - 2027 (USD Million)
    • 6.2.3. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.2.4. U.S.
      • 6.2.4.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.2.4.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.2.5. Canada
      • 6.2.5.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.2.5.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market size, by country, 2016 - 2027 (USD Million)
    • 6.3.2. Market size, by product, 2016 - 2027 (USD Million)
    • 6.3.3. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.3.4.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.5. UK
      • 6.3.5.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.3.5.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.6. France
      • 6.3.6.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.3.6.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.7. Italy
      • 6.3.7.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.3.7.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.3.8. Spain
      • 6.3.8.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.3.8.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market size, by country, 2016 - 2027 (USD Million)
    • 6.4.2. Market size, by product, 2016 - 2027 (USD Million)
    • 6.4.3. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.4.4.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.4.5. China
      • 6.4.5.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.4.5.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.4.6. India
      • 6.4.6.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.4.6.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.4.7. Australia
      • 6.4.7.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.4.7.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Market size, by country, 2016 - 2027 (USD Million)
    • 6.5.2. Market size, by product, 2016 - 2027 (USD Million)
    • 6.5.3. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.5.4.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.5.5. Brazil
      • 6.5.5.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.5.5.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Market size, by country, 2016 - 2027 (USD Million)
    • 6.6.2. Market size, by product, 2016 - 2027 (USD Million)
    • 6.6.3. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.6.4.2. Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 6.6.5. Saudi Arabia
      • 6.6.5.1. Market size, by product, 2016 - 2027 (USD Million)
      • 6.6.5.2. Market size, by distribution channel, 2016 - 2027 (USD Million)

Chapter 7. Company Profiles

  • 7.1. Strategy dashboard, 2020
  • 7.2. Johnson & Johnson Services Inc.
    • 7.2.1. Business overview
    • 7.2.2. Financial data
    • 7.2.3. Product landscape
    • 7.2.4. Strategic outlook
    • 7.2.5. SWOT analysis
  • 7.3. Pfizer Inc.
    • 7.3.1. Business overview
    • 7.3.2. Financial data
    • 7.3.3. Product landscape
    • 7.3.4. Strategic outlook
    • 7.3.5. SWOT analysis
  • 7.4. Merck & Co. Inc.
    • 7.4.1. Business overview
    • 7.4.2. Financial data
    • 7.4.3. Product landscape
    • 7.4.4. Strategic outlook
    • 7.4.5. SWOT analysis
  • 7.5. Sanofi
    • 7.5.1. Business overview
    • 7.5.2. Financial data
    • 7.5.3. Product landscape
    • 7.5.4. Strategic outlook
    • 7.5.5. SWOT analysis
  • 7.6. Takeda Pharmaceuticals
    • 7.6.1. Business overview
    • 7.6.2. Financial data
    • 7.6.3. Product landscape
    • 7.6.4. Strategic outlook
    • 7.6.5. SWOT analysis
  • 7.7. GlaxoSmithKline plc
    • 7.7.1. Business overview
    • 7.7.2. Financial data
    • 7.7.3. Product landscape
    • 7.7.4. Strategic outlook
    • 7.7.5. SWOT analysis
  • 7.8. Teva Pharmaceutical Industries Ltd.
    • 7.8.1. Business overview
    • 7.8.2. Financial data
    • 7.8.3. Product landscape
    • 7.8.4. Strategic outlook
    • 7.8.5. SWOT analysis
  • 7.9. Bayer AG
    • 7.9.1. Business overview
    • 7.9.2. Financial data
    • 7.9.3. Product landscape
    • 7.9.4. Strategic outlook
    • 7.9.5. SWOT analysis
  • 7.10. Galderma
    • 7.10.1. Business overview
    • 7.10.2. Financial data
    • 7.10.3. Product landscape
    • 7.10.4. Strategic outlook
    • 7.10.5. SWOT analysis

Data Tables

  • TABLE 1. Prurigo nodularis treatment market, 2016-2020 (USD Million)
  • TABLE 2. Prurigo nodularis treatment market, 2021-2027 (USD Million)
  • TABLE 3. Prurigo nodularis treatment market, by product, 2016-2020 (USD Million)
  • TABLE 4. Prurigo nodularis treatment market, by product, 2021-2027 (USD Million)
  • TABLE 5. Prurigo nodularis treatment market, by distribution channel, 2016-2020 (USD Million)
  • TABLE 6. Prurigo nodularis treatment market, by distribution channel, 2021-2027 (USD Million)
  • TABLE 7. Prurigo nodularis treatment market, by region, 2016-2020 (USD Million)
  • TABLE 8. Prurigo nodularis treatment market, by region, 2021-2027 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Antihistamines market size, by region, 2016-2020 (USD Million)
  • TABLE 11. Antihistamines market size, by region, 2021-2027 (USD Million)
  • TABLE 12. Capsaicin cream market size, by region, 2016-2020 (USD Million)
  • TABLE 13. Capsaicin cream market size, by region, 2021-2027 (USD Million)
  • TABLE 14. Corticosteroids market size, by region, 2016-2020 (USD Million)
  • TABLE 15. Corticosteroids market size, by region, 2021-2027 (USD Million)
  • TABLE 16. Emollients market size, by region, 2016-2020 (USD Million)
  • TABLE 17. Emollients market size, by region, 2021-2027 (USD Million)
  • TABLE 18. Others market size, by region, 2016-2020 (USD Million)
  • TABLE 19. Others market size, by region, 2021-2027 (USD Million)
  • TABLE 20. Hospital pharmacies market size, by region, 2016-2020 (USD Million)
  • TABLE 21. Hospital pharmacies market size, by region, 2021-2027 (USD Million)
  • TABLE 22. Retail pharmacies market size, by region, 2016-2020 (USD Million)
  • TABLE 23. Retail pharmacies market size, by region, 2021-2027 (USD Million)
  • TABLE 24. Online pharmacies market size, by region, 2016-2020 (USD Million)
  • TABLE 25. Online pharmacies market size, by region, 2021-2027 (USD Million)
  • TABLE 26. North America prurigo nodularis treatment market size, by country, 2016-2020 (USD Million)
  • TABLE 27. North America prurigo nodularis treatment market size, by country, 2021-2027 (USD Million)
  • TABLE 28. North America prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 29. North America prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 30. North America prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 31. North America prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 32. U.S. prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 33. U.S. prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 34. U.S. prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 35. U.S. prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 36. Canada prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 37. Canada prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 38. Canada prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 39. Canada prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 40. Europe prurigo nodularis treatment market size, by country, 2016-2020 (USD Million)
  • TABLE 41. Europe prurigo nodularis treatment market size, by country, 2021-2027 (USD Million)
  • TABLE 42. Europe prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 43. Europe prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 44. Europe prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 45. Europe prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 46. Germany prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 47. Germany prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 48. Germany prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 49. Germany prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 50. UK prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 51. UK prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 52. UK prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 53. UK prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 54. France prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 55. France prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 56. France prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 57. France prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 58. Spain prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 59. Spain prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 60. Spain prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 61. Spain prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 62. Italy prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 63. Italy prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 64. Italy prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 65. Italy prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 66. Asia Pacific prurigo nodularis treatment market size, by country, 2016-2020 (USD Million)
  • TABLE 67. Asia Pacific prurigo nodularis treatment market size, by country, 2021-2027 (USD Million)
  • TABLE 68. Asia Pacific prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 69. Asia Pacific prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 70. Asia Pacific prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 71. Asia Pacific prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 72. China prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 73. China prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 74. China prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 75. China prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 76. India prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 77. India prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 78. India prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 79. India prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 80. Japan prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 81. Japan prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 82. Japan prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 83. Japan prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 84. Australia prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 85. Australia prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 86. Australia prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 87. Australia prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 88. Latin America prurigo nodularis treatment market size, by country, 2016-2020 (USD Million)
  • TABLE 89. Latin America prurigo nodularis treatment market size, by country, 2021-2027 (USD Million)
  • TABLE 90. Latin America prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 91. Latin America prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 92. Latin America prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 93. Latin America prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 94. Brazil prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 95. Brazil prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 96. Brazil prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 97. Brazil prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 98. Mexico prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 99. Mexico prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 100. Mexico prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 101. Mexico prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 102. MEA prurigo nodularis treatment market size, by country, 2016-2020 (USD Million)
  • TABLE 103. MEA prurigo nodularis treatment market size, by country, 2021-2027 (USD Million)
  • TABLE 104. MEA prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 105. MEA prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 106. MEA prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 107. MEA prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 108. South Africa prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 109. South Africa prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 110. South Africa prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 111. South Africa prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)
  • TABLE 112. Saudi Arabia prurigo nodularis treatment market size, by product, 2016-2020 (USD Million)
  • TABLE 113. Saudi Arabia prurigo nodularis treatment market size, by product, 2021-2027 (USD Million)
  • TABLE 114. Saudi Arabia prurigo nodularis treatment market size, by distribution channel, 2016-2020 (USD Million)
  • TABLE 115. Saudi Arabia prurigo nodularis treatment market size, by distribution channel, 2021-2027 (USD Million)

Charts & Figures

  • FIG. 1 Market estimation approach
  • FIG. 2 Data validation
  • FIG. 3 Prurigo nodularis treatment industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 Global prurigo nodularis market, 2016-2027 (USD Million)
  • FIG. 6 Growth potential analysis, by product
  • FIG. 7 Growth potential analysis, by distribution channel
  • FIG. 8 Porter's analysis
  • FIG. 9 Company matrix analysis, 2020
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by product
  • FIG. 12 Key segment trends, by distribution channel
  • FIG. 13 Key regional trends
  • FIG. 14 Strategy dashboard, 2020
Back to Top